Outcomes for Lumbar Decompressions With Use of Liposomal Bupivicaine

Recruiting now · Phase 2

Conditions studied: Lumbar Spinal Stenosis

In brief

Evaluate the benefit of using liposomal bupivicaine in lumbar laminectomies in terms of length of stay, IV narcotic use, 30-day narcotic use, visual analog score (VAS) and 30-day readmissions

Key facts

Study ID

NCT04066296

Run by

University of Colorado, Denver

People needed

100

Starts

2019-09-08

Expected to finish

2025-01-01

Last updated by the study team

2024-10-01

Who can join

Age: 18 and older. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

• Male or Female
• Adult (≥18 yo)
• Lumbar stenosis

You may not qualify if…

• Co-morbidities precluding surgery
• ≤18 yo
• Pregnant
• Breastfeeding
• Need for instrumented fusion
• Prisoners
• Intra-operative CSF leak (identified by gush of CSF)
• Daily pre-operative opioid use of > 25 morphine Eq/day
• Previous lumbar surgery at indicated level

Where it is running

• University of Colorado Anschutz Medical Campus — Aurora, Colorado, United States (enrolling)

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.